TEKLA CAPITAL MANAGEMENT
Tekla Capital Management LLC is a registered investment adviser based in Boston, Massachusetts, and is currently the investment adviser for two closed-end equity funds, H&Q Healthcare Investors and H&Q Life Sciences Investors. The Funds invest in growth equities, both public and private, in the healthcare and life sciences industries.
TEKLA CAPITAL MANAGEMENT
Social Links:
Industry:
Finance Financial Services Health Care Venture Capital
Founded:
1986-06-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
SPF GoDaddy DNS Digital Ocean GoDaddy SSL Pardot Mail Intermedia
Similar Organizations
Alethea Capital Management
Alethea Capital Management is an SEC-registered investment advisor founded in March of 2011
Angel Capital Management
Angel Capital Management is a leading private investment firm.
Hammer Capital Management
Hammer Capital Management is a principal investment firm and investment advisor.
Interplay
Interplay is a New York City-based venture capital firm focused on investing in technology-enabled businesses between Seed and Series B.
MassMutual Ventures
MMV is a multi-stage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health.
New Enterprise Associates
New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
Optum Ventures
Optum Ventures provides capital and strategic guidance to startup companies solving health care's pressing challenges.
Ranger Global Real Estate Advisors
Ranger Global Real Estate Advisors is an SEC registered as an investment adviser that provides investment management services to various.
Saba Capital Management
Saba Capital Management, L.P. (“Saba”) is an Investment Adviser launched in 2009.
The CAPROCK Group
The CAPROCK Group is a multi-family office which helps to grow their clients by giving financial solutions.
Current Advisors List
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-04-24 | Endeavor BioMedicines | Tekla Capital Management investment in Series C - Endeavor BioMedicines | 132.5 M USD |
| 2023-03-03 | Oculis | Tekla Capital Management investment in Post-IPO Equity - Oculis | 91 M USD |
| 2023-01-06 | Amolyt Pharma | Tekla Capital Management investment in Series C - Amolyt Pharma | 130 M EUR |
| 2022-05-10 | Invetx | Tekla Capital Management investment in Series B - Invetx | 60.5 M USD |
| 2022-04-06 | MoonLake Immunotherapeutics | Tekla Capital Management investment in Post-IPO Equity - MoonLake Immunotherapeutics | 115 M USD |
| 2022-02-10 | Arkuda Therapeutics | Tekla Capital Management investment in Series B - Arkuda Therapeutics | 64 M USD |
| 2022-02-07 | Endeavor BioMedicines | Tekla Capital Management investment in Series B - Endeavor BioMedicines | 101 M USD |
| 2021-11-29 | Quell Therapeutics | Tekla Capital Management investment in Series B - Quell Therapeutics | 156 M USD |
| 2021-11-09 | Arbor Biotechnologies | Tekla Capital Management investment in Series B - Arbor Biotechnologies | 215 M USD |
| 2021-11-03 | Parthenon Therapeutics | Tekla Capital Management investment in Series A - Parthenon Therapeutics | 65 M USD |
More informations about "Tekla Capital Management"
Tekla Capital Management - LinkedIn
Tekla Capital Management Financial Services Boston, Massachusetts 463 followers Tekla Capital is an asset manager primarily focused on healthcare investing.See details»
Abrdn acquires £2.6bn healthcare funds with Tekla …
Jun 21, 2023 Abrdn has acquired the healthcare fund management capabilities of Boston-based Tekla Capital Management. By David Ricketts. Share. Resize. As part of the deal, Abrdn will acquire four listed healthcare and biotech …See details»
US Specialist Healthcare | Closed-End Funds | abrdn
Jun 21, 2023 abrdn plc today announced that its U.S. subsidiary abrdn Inc. has entered into an agreement to acquire the healthcare fund management capabilities of Tekla Capital …See details»
Tekla Capital: Healthcare Megatrends and Closed-End …
Closed-End Fund Specialists. The Tekla acquisition comprised four NYSE-listed closed-end funds with £2.6bn in assets under management. Closed-end funds (CEFs) remain a key area of strength for abrdn, with the acquisition of four …See details»
Tekla Capital Management - PitchBook
Tekla Capital Management has invested in or acquired companies like ReCode Therapeutics, Abcuro, and Oculis Holding. What are Tekla Capital Management subsidiaries? Tekla Healthcare Investors is a subsidiary of Tekla Capital …See details»
Tekla Capital Management LLC Announces Closing of Transaction …
Oct 27, 2023 HQH, HQL, THQ, THW Tekla Capital Management LLC (Tekla) announced today that it has completed the sale of its advisory business to abrdn Inc. In additSee details»
abrdn to Acquire US Specialist Healthcare Closed-End Funds with …
Jun 20, 2023 abrdn plc today announced that its U.S. subsidiary abrdn Inc. has entered into an agreement to acquire the healthcare fund management capabilities of Tekla Capital …See details»
Tekla Capital Management - Investments, Portfolio & Company Exits
Tekla Capital Management is an investment adviser. Invetx Invetx is a veterinary therapeutics company that develops protein-based therapeutics for the treatment of various animal diseases.See details»
Tekla Capital Management LLC - Company Profile and News
Tekla Capital Management LLC operates as an investment management firm. The Company provides investment services to public and private, debt, and pooled investment vehicles in the …See details»
Tekla Capital Management LLC Announces Proposed Transaction
Jun 20, 2023 Tekla Capital Management LLC announced today that it has entered into an agreement with abrdn Inc. for a strategic transaction involving four NYSE-listed healthcare& …See details»
Tekla Capital Management LLC (Boston) | Adviser Rankings
Tekla Capital Management: assets under management The assets under management (AUM) of Tekla Capital Management LLC is $2.75 billion , all of which is managed in discretionary …See details»
Tekla Funds Approve New Investment Advisory Agreements With …
Oct 27, 2023 Tekla Capital Management LLC announced today that the requisite vote has been attained to approve the new investment advisory agreement with abrdn Inc. for each of its four …See details»
Tekla Capital Management Portfolio Companies - Crunchbase
Feb 16, 2010 Tekla Capital Management is an investment adviser. This list of organizations invested in by Tekla Capital Management provides data on their funding history, investment …See details»
Tekla Capital Management LLC Announces Proposed Transaction
Jun 20, 2023 BOSTON--(BUSINESS WIRE)--Tekla Capital Management LLC (Tekla) announced today that it has entered into an agreement with abrdn Inc. for a strategic …See details»
Tekla Capital Management 13F annual report (2024) - wallmine
$2.56 trillion Assets Under Management (AUM) As of 3rd August 2023, Tekla Capital Management’s top holding is 616,539 shares of AMGEN currently worth over $137 billion and …See details»
THQ: Still The Best Of The Tekla Suite - Seeking Alpha
Tekla Capital Management is a boutique healthcare investment specialist based in Boston, Massachusetts and is the investment adviser for four closed-end funds: Tekla Healthcare …See details»
Daniel R. Omstead - Chief Executive Officer @ Tekla Capital …
Daniel R. Omstead, Ph.D., is the Chief Executive Officer of Tekla Capital Management, LLC. He is also President of H&Q Lifesciences Investors and H&Q Healthcare Investors, two NYSE …See details»
Tekla Medical Science Innovation Portfolio Series 5
Nov 21, 2022 Tekla Capital Management, LLC is a Registered Investment Adviser that specializes in healthcare sector investing. ... (“COVID-19”) was first detected in December …See details»
Tekla Capital Management - Contacts, Employees, Board
Tekla Capital Management has 8 current employee profiles, including Senior Vice President, Research Jason C. Akus. Tekla Capital Management has 1 board member or advisor, Jeffrey …See details»